MAY 10, 2017 10:30 AM PDT

Methods to account for sequencing artifacts in large high-throughput RNA-Seq data

C.E. CREDITS: CEU | P.A.C.E. CE | Florida CE
Speakers
  • Research Fellow, Dana-Farber Cancer Institute
    Biography
      I am a Research Fellow in the Department of Biostatistics and Computational Biology at the Dana-Farber Cancer Institute and Department of Biostatistics at the Harvard TH Chan School of Public Health under the guidance of Professor John Quackenbush. Prior to joining Harvard I was a National Science Foundation Graduate Research Fellow at the University of Maryland, College Park where I received my Ph.D. in Applied Mathematics, Statistics and Scientific Computation.
      As a computer scientist and computational biologist, my interests are to develop computational methods for the analysis of high-throughput sequencing data. I also desire to develop software and support these methods as open-source software for the broader scientific community through Bioconductor and popular domain tools such as QIIME and Phyloseq. MetagenomeSeq, is my most popular tool developed and is in the top 5% of all Bioconductor packages downloaded in the last year with over 5,000 unique users. I am excited to leverage statistical and network methodologies in accounting for technological when identifying disease markers.

    Abstract:

    Although ultrahigh-throughput RNA-sequencing has become the dominant technology for genome-wide transcriptional profiling, the vast majority of RNA-seq studies typically profile only tens of samples, and most analytical pipelines are optimized for these smaller studies. However, projects are generating ever-larger data sets comprising RNA-seq data from hundreds or thousands of samples, often collected at multiple locations and from diverse tissues. We examine the effects of different preprocessing methods on downstream analyses. We find analysis of large RNA-seq data sets requires careful quality control and that one account for sparsity due to the heterogeneity intrinsic in multi-group studies. We motivate our results using the GTEx cohort and look at the differential pathways of cell lines from their progenitor tissues.


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    OCT 02, 2019 11:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    OCT 02, 2019 11:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    MAR 26, 2019 02:00 PM PDT
    C.E. CREDITS
    MAR 26, 2019 02:00 PM PDT
    DATE:  March 26, 2019TIME:  2:00pm PDT, 5:00pm EDT  Prostate cancer is the second most common form of cancer in males, affecting one in eight men by the time t...
    Loading Comments...
    Show Resources